Venglustat in Combination with Cerezyme in Adult Patients with Gaucher Disease Type 3 with venglustat monotherapy extension

Trial Identifier: PDY13949
Sponsor: Genzyme, a Sanofi Company
Start Date: January 2017
Primary Completion Date: October 2026
Study Completion Date: October 2026
Condition: Gaucher Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
GERMANY Mainz, GERMANY, 55131
JAPAN, Tokyo Minato-ku, Tokyo, JAPAN, 105-8471
UNITED KINGDOM, Cambridgeshire Cambridge, Cambridgeshire, UNITED KINGDOM, CB2 OQQ
UNITED KINGDOM, Manchester Salford, Manchester, UNITED KINGDOM, M6 8HD
UNITED STATES, Connecticut New Haven, Connecticut, UNITED STATES, 06520
UNITED STATES, Texas Dallas, Texas, UNITED STATES, 75226
UNITED STATES, Virginia Fairfax, Virginia, UNITED STATES, 22030